Seattle Genetics Inc SGEN:NASDAQ

Last Price$109.00NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/17/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$108.95 (1)
Ask (Size)$109.01 (4)
Day Low / HighN/A - N/A
Volume745.7 K
 

View Biotechnology IndustryPeer Comparison as of 01/17/2020

 

Seattle Genetics Inc ( NASDAQ )

Price: $109.00
Change: +1.34 (1.24%)
Volume: 745.7 K
4:00PM ET 1/17/2020
 
 

Incyte Corp ( NASDAQ )

Price: $80.50
Change: -0.12 (0.15%)
Volume: 1.4 M
4:00PM ET 1/17/2020
 
 

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $88.27
Change: -0.86 (0.96%)
Volume: 1.7 M
4:00PM ET 1/17/2020
 
 

Alnylam Pharmaceuticals Inc ( NASDAQ )

Price: $118.82
Change: -0.52 (0.44%)
Volume: 860.4 K
4:00PM ET 1/17/2020
 
 

Exact Sciences Corp ( NASDAQ )

Price: $88.06
Change: -1.72 (1.92%)
Volume: 3.0 M
4:00PM ET 1/17/2020
 

Read more news Recent News

Insider Trends: Insider at Seattle Genetics Converts Options in Mist of 90-Day Buying Trend
8:34PM ET 1/09/2020 MT Newswires

Daniel G Welch, Director, on Jan 07, 2020, exercised options for 17,500 shares in Seattle Genetics (SGEN) for $223,300. Following the Form 4 filing with...

Analyst Actions: Guggenheim Downgrades Seattle Genetics to Neutral From Buy
9:54AM ET 1/02/2020 MT Newswires

Seattle Genetics (SGEN) has an average analyst rating of buy, with an average price target of $115. Price: 113.05, Change: -1.21, Percent Change: -1.06 ...

Sector Update: Health Care Stocks Hanging On To Monday Advance
3:56PM ET 12/23/2019 MT Newswires

Top Health Care Stocks JNJ +0.35% PFE +0.13% ABT +0.67% MRK +0.14% AMGN +0.03% Health care stocks continue to edge higher in late trade, with the NYSE...

Sector Update: Health Care
3:48PM ET 12/23/2019 MT Newswires

Health care stocks continue to edge higher in late trade, with the NYSE Health Care Index climbing just over 0.3% this afternoon while the shares of health...

View all Commentary and Analysis

Biotech Bonanza: 2020 Outlook In An Election Year
4:15PM ET 1/08/2020 Seeking Alpha

The Fastest Growing Large-Cap Stocks In 2020
6:49AM ET 1/06/2020 Seeking Alpha

Stocks To Watch: Key 2020 Events And Catalysts
8:22AM ET 1/01/2020 Seeking Alpha

Christmas Comes Early: The Nasdaq 100 Rebalance Creates A Buying Opportunity
6:17PM ET 12/19/2019 Seeking Alpha

Company Profile

Business DescriptionSeattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its product Adcetris is an antibody-drug for the treatment of lymphoma. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. View company web site for more details
Address21823 30th Drive SE
Bothell, Washington 98021
Phone+1.425.527.4000
Number of Employees1,302
Recent SEC Filing01/16/20208-K
Chairman, President & Chief Executive OfficerClay B. Siegall
Chief Financial & Accounting OfficerTodd E. Simpson
Chief Technical OfficerVaughn B. Himes
Senior Vice President-Clinical DevelopmentRobert J. Lechleider

Company Highlights

Price Open$108.41
Previous Close$107.66
52 Week Range$62.90 - 122.36
Market Capitalization$18.7 B
Shares Outstanding171.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement02/06/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.87
Beta vs. S&P 500N/A
Revenue$654.7 M
Net Profit Margin-37.97%
Return on Equity-21.59%

Analyst Ratings as of 12/31/2019

Buy
11
Overweight
0
Hold
8
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset